A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group-Reference-Cited by-同舟云学术

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group

Published:2013-02 Issue:1 Volume:25 Page:49-55
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Kontopodis Emmanouil,Hatzidaki Dora,Varthalitis Ioannis,Kentepozidis Nikolaos,Giassas Stylianos,Pantazopoulos Nikolaos,Vardakis Nikolaos,Rovithi Maria,Georgoulias Vassilis,Agelaki Sofia

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference43 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

2. Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials

3. First- and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view

4. Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens

5. Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic chemotherapy as a potential partner of immune checkpoint inhibitors for metastatic colorectal cancer treatment;Cancer Letters;2023-07

2. Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer;Cancer Chemotherapy and Pharmacology;2022-07-22

3. Metronomic oral vinorelbine doublet chemotherapy with carboplatin in treatment of advanced lung cancer: a feasibility and safety study;F1000Research;2021-07-28

4. Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection;Lung Cancer;2021-03

5. De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?;Critical Reviews in Oncology/Hematology;2021-01